Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and is mediated ...

[41] Airway Hyper-responsiveness. Wollin and colleagues compared the anti-inflammatory effects of roflumilast with those of other PDE4 inhibitors including rolipram, piclamilast and cilomilast in ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For patients with plaque or guttate psoriasis, home-based phototherapy proved to be least as effective as office-based ...

Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial... Radiopharma Advancell raises $112M ...

or interleukin inhibitors, for moderate to severe psoriasis when other treatments don’t work. If you have moderate to severe psoriasis that hasn’t responded to other treatments, such as ...

QX004N, an interleukin-23 inhibitor, showed safety and efficacy in the treatment of moderate to severe plaque psoriasis, according to a study. QX004N, an IL-23 inhibitor, showed safety and ...

tumor necrosis factor inhibitors (TNFi). The study grouped 32,098 patients with psoriasis or psoriatic arthritis (PsA) into their respective categories based on biologic treatment, which included ...

Whether you suffer from psoriasis yourself or have heard about it from a famous Kardashian who has been very transparent about her symptoms, you know that the skin condition is far from glamorous and ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.